Apart from the normal anthropometric differences, within patients free from P2Y12 inhibitors women had a higher ejection fraction and NYHA class; a lower rate of stable coronary disease and diabetes; a lower hematocrit, serum creatinine value, and a higher serum bilirubin value. Here, P2RY12 is linked to coronary artery disorder.